HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

FAM (5-fluorouracil, doxorubicin, and mitomycin) plus triazinate (FAM-T) in gastric carcinoma: a combined phase II trial of the Mid-Atlantic Oncology Program and the Pan American Health Organization.

AuthorsJ D Ahlgren, F P Smith, E Cazap, R A Estevez, A Marantz, P V Woolley, T Wilcosky, J Stein, P S Schein
JournalCancer treatment reports (Cancer Treat Rep) Vol. 71 Issue 4 Pg. 419-20 (Apr 1987) ISSN: 0361-5960 [Print] United States
PMID3548959 (Publication Type: Clinical Trial, Journal Article, Research Support, U.S. Gov't, P.H.S.)
Chemical References
  • Mitomycins
  • Triazines
  • Mitomycin
  • Doxorubicin
  • triazinate
  • Fluorouracil
Topics
  • Adenocarcinoma (drug therapy)
  • Adult
  • Aged
  • Antineoplastic Combined Chemotherapy Protocols (adverse effects, therapeutic use)
  • Clinical Trials as Topic
  • Doxorubicin (administration & dosage)
  • Drug Administration Schedule
  • Drug Evaluation
  • Female
  • Fluorouracil (administration & dosage)
  • Humans
  • Male
  • Middle Aged
  • Mitomycin
  • Mitomycins (administration & dosage)
  • Stomach Neoplasms (drug therapy)
  • Triazines (administration & dosage)

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown: